• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Wilbe

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Cyclana Bio raises £5m pre-seed led by NfX and Eka VC to advance drug discovery for endometriosis through tissue-level therapeuticsCyclana Bio raises £5m pre-seed led by NfX and Eka VC to advance drug discovery for endometriosis through tissue-level therapeutics
    Cyclana Bio
    20 Oct 2025

    Cyclana Bio raises £5m pre-seed led by NfX and Eka VC to advance drug discovery for endometriosis through tissue-level therapeutics

    Cyclana Bio develops tissue level disease models to discover new treatments for endometriosis, using whole tissue analysis rather than traditional cell focused drug discovery methods.

Wilbe
    • Life Sciences
  • 1(12 months)
  • wilbe.com/home
  • Update Information

More venture news

  • ManaMind secures a £1.1m pre-seed round led by SVV to develop autonomous QA agents for gaming
    ManaMind
    30 Apr 2026

    ManaMind secures a £1.1m pre-seed round led by SVV to develop autonomous QA agents for gaming

    Pre-seedDeveloper Tools
  • Cnuic raises a £2.2m pre-seed round led by Tensor Ventures to develop light-based chip production
    Cnuic Technologies
    28 Apr 2026

    Cnuic raises a £2.2m pre-seed round led by Tensor Ventures to develop light-based chip production

    Pre-seedDeep Tech
  • Calibre raises a £2.4m pre-seed round led by Amino Collective to tackle health guesswork with personalised health platform
    Calibre
    21 Apr 2026

    Calibre raises a £2.4m pre-seed round led by Amino Collective to tackle health guesswork with personalised health platform

    Pre-seedHealth

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn